One big benefit that comes from owning pharmaceutical stocks is that their products remain in demand even during periods of economic stress. That allows drugmakers to crank out profits even when the economy catches a cold.
So what pharmaceutical stocks should investors buy this year? Here’s why I think that Pfizer (NYSE: PFE), Teligent (NASDAQ: TLGT), and Neurocrine Biosciences (NASDAQ: NBIX) are excellent choices.
Image source: Getty Images.